Company Filing History:
1 out of 4 
1 out of 3 Years Active: 2025
Title: Emanuela Dylgjeri: Innovating Cellular Delivery Systems
Introduction: Emanuela Dylgjeri, an accomplished inventor based in Hatfield, Pennsylvania, has made significant contributions to the field of biotechnology. With one patent to her name, her innovative work focuses on the targeted delivery of active agents within cellular environments, promising advancements in medical treatment methodologies.
Latest Patents: Emanuela Dylgjeri holds a patent titled "Cellular delivery of DNA intercalating agents". This patent presents compositions and methods designed for the targeted delivery of active agents to specific cells. The compositions consist of a wholly or partially double-stranded synthetic DNA carrier, intercalated with active agents in the double-stranded regions. Additionally, the DNA carrier can be associated with a targeting agent, enhancing its ability to deliver cytotoxic agents to designated cell types.
Career Highlights: Throughout her career, Emanuela has worked with notable organizations that have propelled her research forward. She has gained valuable experience at Code Biotherapeutics, Inc. and Lankenau Institute of Medical Research. These positions have equipped her with vital insights and skills in the biotherapeutic arena.
Collaborations: Emanuela has had the privilege of collaborating with respected colleagues such as Robert C. Getts and James Kadushin. These partnerships have fostered a collaborative spirit in her work, contributing to the advancement of her innovative projects.
Conclusion: Emanuela Dylgjeri exemplifies the spirit of innovation in biotechnology through her pioneering work in DNA delivery systems. Her patent reflects the potential to revolutionize medical treatments by allowing precise targeting of active agents within the body. With her ongoing contributions, she continues to inspire future advancements in the field.